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Immunity is critical for survival in a world plagued by pathogens.
Like that of most military operations, the strategy of the immune
system is based on acceptable losses: determining the maximal
amount of damage to uninfected tissues that is necessary to
defeat or entrap any invading pathogen. This characteristic has
devastating consequences for patients with immune-mediated
diseases, including many neurological conditions. However, nature
often creates a system of “checks and balances”, and the immune
system is no exception, having developed a repair strategy to
mitigate unwanted tissue damage resulting from leukocyte
responses to microbes. It is unclear whether such strategies are
also used at sites of sterile injury. Sas and colleagues recently
described a novel neutrophil subpopulation that is capable of
promoting nerve repair following acute injury.1
Immunosuppressive leukocytes were first described in 1977,
in which Kung demonstrated that myeloid cells expressing
arginase 1 (Arg1) were capable of suppressing cytotoxic
responses.2 Over the last 40+ years, a growing body of evidence
has attributed immunosuppressive or regenerative properties to
subpopulations of myeloid cells that express Arg1 and the
mannose receptor (CD206), coining the terms alternatively
activated cells, unconventional cells, M2 macrophages and N2
neutrophils. These cellular functions can be replicated in vitro by
polarizing myeloid cells with cytokines or growth factors:
monocytes stimulated with IL-4 or IL-133 and neutrophils
stimulated with TGFβ or GM-CSF.4 Furthermore, the presence
of these cells has been described at sites of wound repair, such
as the skin5 and spinal cord,6 and these cells are thought to be
an important source of resolution and reparative factors, such as
IL-10 and TGFβ.
The infiltration of proinflammatory leukocytes into the central
nervous system (CNS) is considered detrimental in the context of
multiple sclerosis (MS7) and stroke.8 But this represents only half
of the story: CNS-resident macrophages (microglia) with an M2-
like phenotype (Arg1+) are present in MS patients entering
clinical remission.9 Indeed, the switch to the M2 microglial
phenotype has been reported to coincide with the differentia-
tion of murine progenitor cells into myelin sheath-forming
oligodendrocytes to repair regions of toxin-induced demyelina-
tion in the brain.10 Other studies have suggested that it is the
early infiltration of Ly6G+ neutrophils, rather than monocytes,
who secrete regenerative factors (e.g., oncomodulin10) and are
therefore the principal regulators of optic nerve regeneration10
and spinal cord repair [e.g.,6]. Despite these early studies, gaps
in our knowledge remain, such as which signals promote
neutrophils to switch from tissue-damaging to tissue-repairing
functions.
To address this knowledge gap, Sas et al. used a CNS injury and
regeneration model in which the optic nerve was crushed,
resulting in neuronal death that was rescued by intraocular
zymosan, which triggers myeloid cell repair processes.11,12 Using
this optic nerve crush zymosan model, Segal and colleagues
revealed that neutrophils were the predominant cell type in the
vitreous fluid during the critical timeframe for stimulating retinal
ganglion cell repair and axon regeneration. Immunofluorescence
imaging was used to count the number of regenerating axons in
optic nerve sections and the distance of these axons from the
crush site. Importantly, the researchers observed this repair
response in T and B cell-deficient (Rag1−/−) mice, indicating that
myeloid cells were responsible for driving this response. To
confirm this finding, Segal and colleagues attempted to block the
entry of mature neutrophils into the injured eye by systemically
injecting a functional blocking antibody against CXCR2 immedi-
ately after inducing optic nerve crush and administering zymosan.
Rather than observing the loss of axon regeneration due to a
reduce neutrophil infiltrate in the eye, anti-CXCR2 treatment
enhanced the number of axons within and extending away from
the crush site, and also delayed the infiltration of myeloid cells
expressing the neutrophil marker CD11b - raising the question:
what were these cells?
Using flow cytometric analysis, Sas et al. revealed that anti-
CXCR2 treatment triggered the expansion of a population of
arginase 1-expressing neutrophils in the blood and vitreous fluid
that shared characteristics associated with immature neutrophils
(CD14+Ly6GlowCD101low-neg with ring-shaped nuclei). Single-cell
RNA-seq analysis of Ly6G+ cells confirmed these findings and
revealed an abundance of Arg1, Mrc1, and Il4ra transcripts, which
are associated with N2 neutrophils, that were enriched in the
immature neutrophil cluster. Furthermore, the group demon-
strated that intraocular, but not blood, Ly6G+ cells were capable
of stimulating neurite outgrowth when cocultured with primary
retinal ganglion cells in vitro.
The low yield of purified Ly6Glow cells from vitreous fluid
prohibited their use in adoptive transfer experiments. As an
alternative, Segal and colleagues adoptively transferred peritoneal
neutrophils obtained 3 days after zymosan-induced peritonitis (3d
neutrophils). First, the group validated that 3d neutrophils shared
similar traits to intraocular neutrophils harvested from the optic
nerve crush zymosan model following anti-CXCR2 treatment,
including relatively low surface expression of Ly6G and CD101 and
high expression of Arg1, Mrc1, and Il4ra transcripts. Crucially, these
cells stimulated an increase in the number of axons observed
within and extending away from the crush site when adoptively
transferred directly into the eyes of mice with optic nerve crush.
These results were consistent the effects that Sas et al. had
previously observed when zymosan and anti-CXCR2 treatment
were administered at the time of optic nerve crush injury.
Validating adoptive transfer studies in transgenic mice confirmed
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that this response was specific to these cells and not due to free
zymosan particles or the polarization of monocytes within the eye
to an M2 phenotype.
Two questions remained unanswered: What are the regen-
erative factors/signaling pathways involved? Is this response
limited to the eye microenvironment or shared across neuronal
tissues? To address these questions, Segal and colleagues first
cultured retinal ganglion cells or dorsal ganglia cells with 3d
neutrophils or their conditioned media and observed axonal
outgrowth of neurons in all contexts. Moreover, the researchers
used a traumatic spinal cord injury model to show that 3d
neutrophils were able to stimulate the regrowth of severed axons
beyond the injury site, highlighting the neuroprotective and
regenerative functions of 3d neutrophils in both the optic nerve
and spinal cord. Subsequent multiplex, RT-qPCR and ELISA
analyses revealed high levels of nerve growth factor (NGF) and
insulin-like growth factor-1 (IGF-1) in the conditioned media of
3d neutrophils, and also in vitreous fluid following optic nerve
crush plus zymosan, which were further increased in response to
anti-CXCR2 treatment. A series of loss-of-function and gain-of-
function experiments in vitro and in vivo confirmed that NGF and
IGF-1 were the pro-regenerative agents responsible, in part, for
axon regeneration following optic nerve crush injury.
Finally, the group assessed the capacity of human immature
neutrophils to initiate neuronal repair. The researchers took
advantage of the fact that upon short-term resting culture with
DMSO (dimethylsulfoxide) the human promyelocytic leukemia cell
line (HL-60) exhibits a cell surface antigen profile indicative of
immature neutrophils, expressing high levels of Arg1 and NGF
transcripts and secreting NGF. The group showed that these HL-60
cells were able stimulate axon regeneration when adoptively
transferred into the eyes of Rag1-deficient mice with optic nerve
crush injury or when cocultured with primary retinal ganglion cells
in vitro. Neutralizing HL-60 cell-secreted NGF partly reduced
neurite outgrowth in vitro, indicating that the reparative potential
of immature human granulocytes is mediated in part by a growth
factor-dependent mechanism.
The take-home message from the study is the existence of a
novel myeloid/granulocyte population with neuroprotective and
axon regenerative properties in the context of acute optical nerve
(Fig. 1) and spinal cord injury.1
Some questions remain unanswered. Clearly, the study examined
only one human cell line, HL-60, while immunosuppressive Arg1+
primary human neutrophils have been isolated and described in
several disease states13,14 and in pregnancy.15 It will be important to
ascertain the regenerative properties of these cells before screening
for their presence in patients with CNS injury. Studies are needed to
determine the other soluble mediators acting alongside NGF and
IGF-1 to mediate pro-axon regeneration and the significance, if any,
of the response of glial cells to these agents or to the regenerative
neutrophils in this neuroprotective process. Notably, blood Ly6Glow
cells do not exhibit these reparative properties. Therefore, which
signals (e.g., chemokines) do these cells encounter as they migrate
into the injured site that allow for the acquisition of this function?
Such future work will have huge implications in the development of
neuroprotective, regenerative immunotherapies, which could
involve the generation of autologous regenerative neutrophil-
based therapies and/or biological agents to promote the selective
migration of endogenous regenerative neutrophils or the acquisition
of this phenotype in the injured site.
Fig. 1 Regenerative neutrophils stimulate optic nerve repair. Optic nerve crush injury results in neuronal death that is rescued by intraocular
zymosan administration. This combination of injury and inflammation triggers the premature release of immature neutrophils from the bone
marrow (1). These neutrophils (Ly6GlowCD101low-neg) are recruited to the eye in a CXCR2-independent manner (2) where they receive signals
that stimulate the acquisition of a regenerative phenotype (3). These regenerative neutrophils secrete repair factors, including nerve growth
factors (NGF) and insulin-like growth factor-1 (IGF-1), that stimulate retinal ganglion cell survival and axon regeneration (4). Created with
BioRender.com
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